Regenxbio's competitors

Regenxbio's competitors include Sarepta Therapeutics, ANI Pharmaceuticals, CRISPR Therapeutics and Catalyst Pharmaceuticals
Add company...
Regenxbio
Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
ANI Pharmaceuticals
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
Founding Date
Founding Date
2009
Founding Date
1980
Founding Date
1996
Founding Date
2013
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Rockville, US HQ
Locations
Cambridge, US HQ
Locations
Baudette, US HQ
Baudette, US
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
Locations
Coral Gables, US HQ
Employees
Employees
10713% increase
Employees
197
Employees
143
Employees
93
Employees
18
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
4.6 b
Valuation ($)
674.5 m
Valuation ($)
783.4 m
Valuation ($)
231.5 m
Twitter followers
Twitter followers
319
Twitter followers
302
Twitter followers
N/A
Twitter followers
3.5 k
Twitter followers
436

Financial

Revenue (est.)
Revenue (est.)
$10.4m (FY, 2017)
Revenue (est.)
$154.6m (FY, 2017)
Revenue (est.)
$176.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$7.4m (FY, 2017)
Cost of goods
$79m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$147.2m (FY, 2017)
Gross profit
$97.8m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($73.2m) (FY, 2017)
Net income
($50.7m) (FY, 2017)
Net income
N/A
Net income
($68.4m) (FY, 2017)
Net income
($18.4m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Sarepta Therapeutics
HQ
Cambridge, US
Employees
197

Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.

View company
ANI Pharmaceuticals
HQ
Baudette, US
Employees
143

ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.

View company
CRISPR Therapeutics
HQ
Zug, CH
Employees
93

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company
Catalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
18

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.

View company